METHOD AND APPARATUS FOR CLINICAL WIDGET DISTRIBUTION

• US 20100131283A1
• Filed: 11/26/2008
• Published: 05/27/2010
• Est. Priority Date: 11/26/2008
• Status: Abandoned Application

• Current Assignee: General Electric Company
• Original Assignee: General Electric Company
• Inventors: Della Penna, Michael A., Linthicum, Steven, Fors, Steven, Jester, Eric, Ricamato, Anthony
• Application Number:
  US12/324,530
• Publication Number:
  US 20100131283A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/0637 Strategic management or analysis, e.g. setting a goal or target of an organisation; Planning actions based on goals; Analysis or evaluation of effectiveness of goals
• CPC Class Codes: G16H 30/20 for handling medical images, e.g. DICOM, HL7 or PACS
• CPC Class Codes: G16H 70/20 relating to practices or guidelines

Abstract

Certain examples of the presently describe technology provide systems, methods, and apparatus for development, testing, validation, and distribution of third party clinical content via a content provider. Certain examples provide an apparatus for development, validation, and distribution of third party clinical content. The apparatus includes a development subsystem providing tools, standard program code, and workflow assistance for user development of clinical content for execution via a clinical interface. The apparatus also includes a certification subsystem automatically facilitating validation and verification of user developed clinical content according to a regulatory specification. The apparatus further includes a distribution subsystem distributing user developed clinical content after approval of the clinical content via the certification subsystem.

Claims

1. An apparatus for development, validation, and distribution of third party clinical content, the apparatus comprising:

a development subsystem providing tools, standard program code, and workflow assistance for user development of clinical content for execution via a clinical interface;

a certification subsystem facilitating validation and verification of user developed clinical content according to a regulatory specification; and

a distribution subsystem distributing user developed clinical content after approval of the clinical content via the certification subsystem.

2. The apparatus of claim 1, further comprising a branding subsystem for branding and packaging approved clinical content according to a content provider.

3. The apparatus of claim 1, wherein the apparatus is associated with a content provider, the content provider assessing a fee for development, certification, and distribution of the clinical content in conjunction with an identifier associated with the content provider.

4. The apparatus of claim 1, wherein the development subsystem provides an application programming interface, one or more tools, and standardized program code for development of the clinical content by a third party user.

5. The apparatus of claim 1, wherein the clinical content comprises a widget for installation and execution in an adaptive user interface for a clinical system.

6. The apparatus of claim 1, wherein the development subsystem allows the user to modify existing clinical content to form new clinical content.

7. The apparatus of claim 1, wherein the certification subsystem automatically facilitates validation and verification of user developed clinical content according to a content provider specification.

8. A method for development, validation, and distribution of third party clinical content, the method comprising:

facilitating third party user development of clinical content via provided tools, standard program code, and workflow assistance, the clinical content developed for execution via a clinical interface;

conducting validation and verification of user developed clinical content according to a regulatory specification; and

distributing user developed clinical content following regulatory approval of the clinical content.

9. The method of claim 8, further comprising branding and packaging approved clinical content according to a content provider.

10. The method of claim 8, further comprising assessing a fee, by the content provider, for development, certification, and distribution of the clinical content in conjunction with an identifier associated with the content provider.

11. The method of claim 8, wherein facilitating third party user development of clinical content further comprises providing an application programming interface, one or more tools, and standardized program code for development of the clinical content by a third party user.

12. The method of claim 8, wherein the clinical content comprises a widget for installation and execution in an adaptive user interface for a clinical system.

13. The method of claim 8, wherein facilitating third party development further comprises facilitating user modification of existing clinical content to form new clinical content.

14. The method of claim 8, further comprising automatically conducting validation and verification of user developed clinical content according to a content provider specification.

15. A machine readable medium having a set of instructions for execution on a computing device, the set of instructions, when executed, providing a framework for development, validation, and distribution of third party clinical content, the set of instructions comprising:

a development subsystem providing tools, standard program code, and workflow assistance for user development of clinical content for execution via a clinical interface;

a certification subsystem facilitating validation and verification of user developed clinical content according to a regulatory specification; and

a distribution subsystem distributing user developed clinical content after approval of the clinical content via the certification subsystem.

16. The machine readable medium of claim 15, wherein the set of instructions further comprises a branding subsystem for branding and packaging approved clinical content according to a content provider.

17. The machine readable medium of claim 15, wherein the development subsystem provides an application programming interface, one or more tools, and standardized program code for development of the clinical content by a third party user.

18. The machine readable medium of claim 15, wherein the clinical content comprises a widget for installation and execution in an adaptive user interface for a clinical system.

19. The a machine readable medium of claim 15, wherein the development subsystem allows the user to modify existing clinical content to form new clinical content.

20. The machine readable medium of claim 15, wherein the certification subsystem automatically facilitates validation and verification of user developed clinical content according to a content provider specification.